Gelonghui, March 14 | Zhaoyan Pharmaceutical, Sailong Pharmaceutical, and Luoxin Pharmaceutical rose and stopped; Zhongsheng Pharmaceutical, Hengrui Pharmaceutical, and Hisco are close to rising or stopping. Eddy Pharmaceuticals, Betta Pharmaceuticals, Biotech, Junshi Biotech, and Colon Pharmaceuticals all strengthened collectively. According to the news, a document on the “Implementation Plan for Supporting the Development of Innovative Drugs in the Whole Chain (Draft for Comments)” was distributed online, which was interpreted by the market as a major benefit for the innovative drug industry.
A股创新药股集体高开，昭衍新药等多股涨停
A-share innovative pharmaceutical stocks collectively opened higher, and many stocks such as Zhaoyan New Pharmaceutical rose and stopped
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.